These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5572347)

  • 1. Lymphocyte transformation in patients with breast cancer.
    Whittaker MG; Clark CG
    Br J Surg; 1971 Apr; 58(4):302. PubMed ID: 5572347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphocyte subsets and response of breast cancer and benign mammary disease to PHA].
    Nakao S; Hayashida K; Hasegawa H; Ishii T; Eida K; Noguchi K
    Gan No Rinsho; 1987 Oct; 33(12):1453-8. PubMed ID: 3500331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43.
    Reinerová M; Veselovská Z; Ausch C; Rosen HR
    Neoplasma; 1996; 43(6):363-6. PubMed ID: 8996559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte transformation in breast cancer.
    Roberts MM
    Br J Surg; 1970 May; 57(5):381. PubMed ID: 5427887
    [No Abstract]   [Full Text] [Related]  

  • 5. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [B cells and serum immunoglobulins in patients with breast pathology].
    Zornoza G; Hernández JL; Sanz ML; Fernández J; Goena I; Lera JM
    Rev Esp Oncol; 1981; 28(1):17-27. PubMed ID: 6984973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc receptor-bearing peripheral blood mononuclear cells in breast cancer patients: a possible marker of tumour burden and prognosis.
    Bray J; McPherson TA
    Clin Exp Immunol; 1981 Jun; 44(3):629-37. PubMed ID: 7035033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic studies of human breast cancer. I. Serum reactivity against a lymphoid cell line (Belev) derived from a breast cancer patient as detected by complement-fixation test.
    Chan SP; Maca RD; Levine PH; Ting RC
    J Natl Cancer Inst; 1971 Sep; 47(3):511-7. PubMed ID: 5157574
    [No Abstract]   [Full Text] [Related]  

  • 9. Recovery of lymphocyte function after radiation therapy for cancer in relationship to prognosis.
    Stratton JA; Fast PE; Weintraub I
    J Clin Lab Immunol; 1982 Feb; 7(2):147-53. PubMed ID: 7069785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lymphocyte blastogenesis responses to mouse mammary tumor virus.
    Wiseman CL; Bowen JM; Davis JW; Hersh EM; Brown BW; Blumenschein GR
    J Natl Cancer Inst; 1980 Mar; 64(3):425-30. PubMed ID: 6243719
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing differences in the concanavalin A-induced blastogenic responses of lymphocytes from breast cancer patients and controls by the use of alpha-methyl-D-mannoside.
    Distasio JA; Cheresh DA; Schilder RJ; Vogel CL; Silverman MA; Lopez DM
    J Natl Cancer Inst; 1982 Jan; 68(1):68-9. PubMed ID: 6948127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CA 15-3 in breast cancer--specificity and diagnostic potential].
    Zito GA; Callipari S; Capuano S; Colella C; Cinque P; Gambardella A; Sacchettino A; Verza M; Varricchio M
    Boll Soc Ital Biol Sper; 1988 Jul; 64(7):667-70. PubMed ID: 3228513
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum antibody in patients with mammary disease.
    Humphrey LJ; Estes NC; Morse PA; Jewell WR; Boudet RA; Hudson MJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1516-20. PubMed ID: 4214083
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of serum from patients with breast cancer.
    Mahoney JC; Boehm OR; Boehm BJ; Humphrey LJ
    Surg Forum; 1972; 23(0):87-8. PubMed ID: 4210083
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitogen-induced blastogenesis and receptor mobility inhibition by breast cancer serum with elevated orosomucoid (alpha 1-acid glycoprotein) levels.
    Cheresh DA; Distasio JA; Vogel CL; Lopez DM
    J Natl Cancer Inst; 1982 May; 68(5):779-83. PubMed ID: 6951088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Depressed lymphocyte transformation in breast cancer and macrophage infiltration of the primary growth.
    Turner DT; McGuire M; Turnbull AR
    Br J Surg; 1976 Aug; 63(8):660. PubMed ID: 953489
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic reactivity in patients with primary operable breast cancer.
    Wanebo HJ; Thaler HT; Hansen JA; Rosen PP; Robbins GF; Urban JA; Oettgen HF; Good RA
    Cancer; 1978 Jan; 41(1):84-94. PubMed ID: 304759
    [No Abstract]   [Full Text] [Related]  

  • 20. [Macrophagic transformation inhibition phenomenon of peripheral blood mononucleocytes in breast cancer].
    Dzhaginian AI; Demchenko TA
    Vopr Onkol; 1981; 27(6):32-5. PubMed ID: 7023040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.